Filing Details
Upstream Bio, Inc. (NASDAQ:UPB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:UPB
Upstream Bio, Inc. (UPB) Files Quarterly Report for Q0
Upstream Bio, Inc. (NASDAQ:UPB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
At publication ·
What changed
Upstream Bio, Inc. (NASDAQ:UPB) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Upstream Bio, Inc. (NASDAQ:UPB) filed its quarterly 10-Q report on August 11, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $7.09 with a market capitalization of $1.5 billion.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last annual filing.
Market Context
Upstream Bio, Inc.'s stock currently trades at $7.09 with a market capitalization of $1.5B.
The 10-Q provides Upstream Bio, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Upstream Bio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View UPB Stock Page
Frequently Asked Questions
Where can I read UPB's SEC filings?
Browse all filings on our UPB SEC filings page.
What types of SEC filings does Upstream Bio, Inc. file?
Public companies like Upstream Bio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.